NL-OMON37073已完成不适用
Assessment and optimisation of carboplatin exposure in pediatric oncology patients using different markers of kidney function - Carboplatin pharmacokinetics
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •Carboplatin therapy, weight above 2.5 kg, central venous line for bloodsampling
排除标准
- •Weight below 2.5 kg, no central venous access for bloodsampling
研究者
相似试验
已完成
不适用
Determination of Carboplatin's Optimal Plasmatic ExposureNeoplasmsNCT00145028Institut Claudius Regaud400
进行中（未招募）
2 期
A Randomised Phase II Study Of nab-paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine CarcinomasACTRN12616000958482Australasian Gastro-Intestinal Trials Group (AGITG)60
尚未招募
不适用
Optimizing carboplatin dosing using Computed Tomography derived body composition and serum creatinineovarian cancerLung cancerNL-OMON56726Amphia Ziekenhuis40
未知
2 期
Phase II study in combination with Carboplatin and TS-1 for Cancer of unknown primaryCancer of unknown primaryJPRN-UMIN000001236ational Cancer Center Hospital, Tokyo35
已完成
2 期
A Phase II Study of daily carboplatin plus irradiation followed by Durvalumab for previously-untreated Stage III NSCLC patients with PS2 and/or high agenon-small cell lung cancerJPRN-jRCTs031190070Kaira Kyoichi95